S. Guardia

Supramaximal Flows: Comparison between Asthmatics and Patients with Chronic Obstructive Pulmonary Disease

H. Sala, Alejandra González, Alejandra Fernández, 2010, Respiration.

CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial

E. Kerwin, H. Watz, F. Maltais, 2020, Respiratory Research.

Supramaximal flow in asthmatic patients

D. Rodenstein, H. Sala, S. Guardia, 1999, European Respiratory Journal.

Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group

G. Peces-Barba, B. Cosío, J. López-Campos, 2022, Archivos de Bronconeumología.

Transient expiratory flow interruptions (TEFI) increase expiratory flow in acute asthma exacerbation.

D. Rodenstein, H. Sala, Alejandra González, 2009, Medicina.

Evaluation of the pulmonary function of patients with severe coronavirus 2019 disease three months after diagnosis.

M. Baldini, H. Sala, S. Guardia, 2021, Medicina.